Not receiving ART, having a CD4-cell count <200 cells/μL, being in WHO HIV clinical stage 4, having other comorbidities, being older, and not receiving co-trimoxazole prophylaxis are some of the major risk factors for unfavorable TB treatment outcomes among patients with HIV associated TB [11,12,13]. This evidence concerns the gene CD4 and tuberculosis.